Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TransIT: MUD HSCT vs IST in Pediatric SAA
NCT02845596Completed
- Start
- Aug 2016
- Primary completion
- Nov 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Randomised, open-label trial of hematopoietic stem cells in aplastic anemia (2 arms). Primary endpoint: Percentage of patients randomized to HSCT that actually complete HSCT at 4 years. Started Aug 2016; status: completed.
02
Drugs
hematopoietic stem cells
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT02845596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02845596.